Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Design|August 25, 2011
Susceptibility genes in hypertensionC Armani, N Botto, M G AndreassiMinerva Endocrinologica|March 25, 2000
[Physiological significance and clinical utility of analytical methods for cardiac natriuretic peptides]S Del Ry, M G Andreassi, D Giannessi, et al.Farmaco (Societa Chimica Italiana : 1989)|June 1, 1996
Synthesis and biological activity of a series of isoindolone derivatives related to cytochalasinsL Pistelli, S Benassi, L Migliore, et al.Life Sciences|June 13, 2001
Endothelin-1, endothelin-1 receptors and cardiac natriuretic peptides in failing human heartS Del Ry, M G Andreassi, A Clerico, et al.Journal of Internal Medicine|September 16, 2004
Oxidative stress and its association with coronary artery disease and different atherogenic risk factorsC Vassalle, L Petrozzi, N Botto, et al.Environmental and Molecular Mutagenesis|June 22, 2000
Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases?M G Andreassi, N Botto, M G Colombo, et al.Mutation Research|August 1, 1994
Induction of binucleation in human lymphocytes by 14 synthetic isoindolone derivatives related to cytochalasinsL Migliore, L Pistelli, S Papa, et al.The British Journal of Radiology|May 30, 2008
Cumulative patient effective dose in cardiologyG Bedetti, N Botto, M G Andreassi, et al.Journal of Hypertension|August 25, 1999
Effects of chronic long-term therapy with calcium antagonists on cytogenetic damage in humansM G Andreassi, E Picano, S Del Ry, et al.European Journal of Heart Failure|August 21, 2001
Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormonesM G Andreassi, S Del Ry, C Palmieri, et al.Pageof 3